The global Obsessive-Compulsive Disorder Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Obsessive-Compulsive Disorder Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Obsessive-Compulsive Disorder Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Obsessive-Compulsive Disorder Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Obsessive-Compulsive Disorder Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AbbVie Inc.
Addex Therapeutics Ltd
C4X Discovery Limited
F. Hoffmann-La Roche Ltd.
Novartis AG
Omeros Corporation
Rottapharm SpA
Sellas Inc.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
ADX-88178
Bitopertin
CR-5542
Dipraglurant IR
Fluvoxamine Maleate
Mavoglurant
Others

Segment by Application
Clinic
Hospital
Research Center